Listing 1 - 3 of 3 |
Sort by
|
Choose an application
Metabolism --- Sphingolipidoses. --- Disorders. --- Sphingolipid storage diseases --- Sphingolipidosis --- Storage diseases, Sphingolipid --- Lipidoses --- Lysosomal storage diseases --- Nervous system --- Disorders of metabolism --- Metabolic diseases --- Metabolic disorders --- Metabolism, Disorders of --- Diseases --- Esfingolípids --- Metabolisme.
Choose an application
Current thinking holds that obesity derives primarily from overnutrition (though compelling arguments for other mechanisms, like endocrine disruption by environmental pollutants, also gain support from the literature). In animals, overnutrition is initially handled by adipose tissue expansion; however, exhaustion of this route of lipid sequestering results in oversupply of lipid to other tissues including skeletal muscle, heart, liver, and others. Failure of these tissues to clear excess lipids through either metabolism or sequestration into putatively inert triacylglycerols results in perturbation of bioactive lipid metabolism in cells. In particular, aberrant generation of bioactive sphingolipids is implicated in a multitude of pathological outcomes of metabolic disease including insulin resistance, inflammation, cardiomyopathy, and others. This volume addresses not only the fundamentals of sphingolipid metabolism and analysis, but also the roles of sphingolipids in these disease processes.
Metabolic Diseases -- pathology. --- Sphingolipidoses. --- Sphingolipids -- metabolism. --- Sphingolipids -- Pathophysiology. --- Sphingolipidoses --- Sphingolipids --- Nutritional and Metabolic Diseases --- Membrane Lipids --- Lipids --- Metabolic Phenomena --- Medicine --- Diseases --- Chemicals and Drugs --- Health Occupations --- Phenomena and Processes --- Disciplines and Occupations --- Metabolic Diseases --- Metabolism --- Pathology --- Biology --- Health & Biological Sciences --- Biophysics --- Pathophysiology --- Pathophysiology. --- Medicine. --- Molecular biology. --- Metabolic diseases. --- Biomedicine. --- Molecular Medicine. --- Metabolic Diseases. --- Disorders of metabolism --- Metabolic diseases --- Metabolic disorders --- Metabolism, Disorders of --- Molecular biochemistry --- Molecular biophysics --- Biochemistry --- Biomolecules --- Systems biology --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Physicians --- Sphingosine --- Sphingolipid storage diseases --- Sphingolipidosis --- Storage diseases, Sphingolipid --- Lipidoses --- Lysosomal storage diseases --- Nervous system --- Health Workforce
Choose an application
Fabry disease is an X-linked inborn error of metabolism wherein deficiency of a lysosomal enzyme results in systemic deposition of glycosphingolipids. Storage deposition, and hence pathological disease, occurs preferentially in renal glomerular and tubular epithelial cells, myocardial cells, heart valve fibrocytes, neurons of dorsal root ganglia, and in endothelial smooth muscle cells of blood vessels. Thus, Fabry disease is a multi-system disorder, albeit with considerable phenotypic heterogeneity in onset and in severity; however, it is progressive, exhibits extensive morbidity, and is life-threatening. Within the past two decades, there has been a radical change in the natural course Fabry disease by virtue of the availability of specific enzyme replacement therapy. Moreover, there has been a concerted effort to better understand the underlying pathology and equally to identify patients prior to the onset of irreversible end-organ damage. It is to be hoped that the future for patients with Fabry disease can be viewed with greater, albeit guarded, optimism. This state-of-the-art textbook attempts to bridge the span of pre-clinical studies, clinical finding, and management options in a readable but comprehensive manner for the medical practitioner as well as the interested non-medical reader.
Lysosomal storage diseases -- Pathogenesis. --- Lysosomal storage diseases -- Treatment. --- Lysosomal storage diseases. --- Lysosomal storage diseases --- Proteins --- Sphingolipidoses --- Cytoplasmic Vesicles --- Metabolic Phenomena --- Genetic Diseases, X-Linked --- Lysosomal Storage Diseases, Nervous System --- Organelles --- Genetic Diseases, Inborn --- Lipidoses --- Phenomena and Processes --- Fabry Disease --- Metabolism --- Lysosomes --- Lysosomal Storage Diseases --- Brain Diseases, Metabolic, Inborn --- Lipid Metabolism, Inborn Errors --- Congenital, Hereditary, and Neonatal Diseases and Abnormalities --- Lipid Metabolism Disorders --- Cytoplasmic Structures --- Metabolism, Inborn Errors --- Brain Diseases, Metabolic --- Diseases --- Cytoplasm --- Metabolic Diseases --- Nutritional and Metabolic Diseases --- Intracellular Space --- Brain Diseases --- Central Nervous System Diseases --- Cellular Structures --- Nervous System Diseases --- Cells --- Anatomy --- Medicine --- Health & Biological Sciences --- Metabolic & Nutritional Diseases --- Disorders --- Disorders. --- Protein metabolism disorders --- Cell storage disorders --- Lysosomal disorders --- Lysosomal enzyme disorders --- Storage diseases, Lysosomal --- Medicine. --- Human genetics. --- Metabolic diseases. --- Medicine & Public Health. --- Metabolic Diseases. --- Human Genetics. --- Metabolism, Inborn errors of --- Genetics --- Heredity, Human --- Human biology --- Physical anthropology --- Disorders of metabolism --- Metabolic diseases --- Metabolic disorders --- Metabolism, Disorders of
Listing 1 - 3 of 3 |
Sort by
|